Reactions Weekly

, Volume 1154, Issue 1, pp 2–2 | Cite as

Prescribing of bicalutamide should be restricted to patients at high risk of disease progression

News item
  • 13 Downloads

Keywords

Public Health Adverse Effect High Risk Prostate Cancer Medicinal Product 

REFERENCE

  1. 1.
    European Medicines Agency.Questions and answers on bicalutamide 150 mg tablets. Internet Document: [2 pages], 24 May 2007. Available from: URL: http://www.emea.europa.eu

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations